0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global High Throughput Screening (HTS) Service Market Research Report 2026
Published Date: 2026-04-16
|
Report Code: QYRE-Auto-37W14379
Home | Market Reports | Computers & Electronics| Software
Global High Throughput Screening HTS Service Market Research Report 2023
BUY CHAPTERS

Global High Throughput Screening (HTS) Service Market Research Report 2026

Code: QYRE-Auto-37W14379
Report
2026-04-16
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

High Throughput Screening (HTS) Service Market Size

The global High Throughput Screening (HTS) Service market was valued at US$ 345 million in 2025 and is anticipated to reach US$ 670 million by 2032, at a CAGR of 10.1% from 2026 to 2032.

High Throughput Screening (HTS) Service Market

High Throughput Screening (HTS) Service Market

HTS is an automated experimental technology that processes thousands to millions of samples (e.g., chemical compounds, biological molecules, cells) in parallel within a short time. It aims to efficiently identify active substances or interactions that meet specific research goals.
To carry out high-throughput screening experiments, facilities often employ automated instruments and liquid handlers in order to test many samples quickly and efficiently. High-throughput screening (HTS) services offer researchers easy access to the experience, expertise, and instrumentation needed to conduct a variety of assays to advance processes in drug discovery and development. HTS applications include enzyme activity assays, molecular binding assays, protein-protein interactions, gene expression screening, compound library screening, cell-based assays, and GPCR assays. HTS-based services often can be tailored to customized requests and the unique requirements of the project. Service providers can also provide technical and scientific advice from the early stages of the project to completion and data analysis.
The global market for high-throughput screening (HTS) services is poised for substantial growth driven by several key factors. The increasing prevalence of chronic diseases, rising demand for personalized medicine, and the expanding drug discovery and development activities are primary drivers fueling the market's expansion. Additionally, advancements in automation technologies, such as robotics and artificial intelligence, are enhancing the efficiency and accuracy of HTS processes, further propelling market growth.
Furthermore, the pharmaceutical and biotechnology sectors are anticipated to remain the dominant end-users of HTS services, given their continuous efforts to expedite drug discovery pipelines and reduce time-to-market for novel therapeutics. Moreover, the adoption of HTS services by academic research institutions and contract research organizations (CROs) is expected to surge, driven by the need for cost-effective and rapid screening solutions.
Geographically, North America is projected to maintain its leadership position in the HTS services market, attributed to the presence of a robust pharmaceutical industry, significant research funding, and a favorable regulatory environment. However, emerging economies in Asia-Pacific, such as China and India, are witnessing rapid growth in HTS adoption due to increasing investments in healthcare infrastructure and research activities.
Despite the promising outlook, challenges such as high initial setup costs, ethical concerns related to the use of animal models, and regulatory complexities may hinder market growth to some extent. Nonetheless, collaborations between industry players, academic institutions, and government bodies, along with continuous technological innovations, are anticipated to mitigate these challenges and drive the market forward.
In summary, the global market for high-throughput screening services is anticipated to witness substantial growth in the coming years, driven by increasing research and development activities, technological advancements, and growing demand for efficient drug discovery solutions. Stakeholders across the pharmaceutical, biotechnology, academic, and CRO sectors are poised to benefit from the expanding opportunities in this dynamic market landscape.
This report delivers a comprehensive overview of the global High Throughput Screening (HTS) Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding High Throughput Screening (HTS) Service. The High Throughput Screening (HTS) Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global High Throughput Screening (HTS) Service market comprehensively. Regional market sizes by Type, by Application, by Detection Technology Principle, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist High Throughput Screening (HTS) Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of High Throughput Screening (HTS) Service Market Report

Report Metric Details
Report Name High Throughput Screening (HTS) Service Market
Accounted market size in 2025 US$ 345 million
Forecasted market size in 2032 US$ 670 million
CAGR 10.1%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Chemical-based HTS Service
  • Biological-based HTS Service
  • Cell-based HTS Service
  • Genetic-based HTS Service
Segment by Detection Technology Principle
  • Fluorescence-based HTS
  • Luminescence-based HTS
  • Label-free HTS
Segment by Sample Format and Scale
  • Microwell Plate-based HTS
  • Droplet-based HTS
  • Array-based HTS
Segment by Application
  • Pharmaceutical Industry
  • Universities and Scientific Research Institutions
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eurofins Discovery, Charles River Laboratories, Axcelead, NUVISAN, Axxam S.p.A., Evotec, Selvita, Azenta Life Sciences, Bienta (Enamine), Cayman Chemical, Creative Biolabs, Creative Bioarray, BOC Sciences, MEDICILON, Domainex, Creative Diagnostics, Multispan, AntalGenics, Creative Biostructure, BPS Bioscience
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Detection Technology Principle, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for High Throughput Screening (HTS) Service companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is High Throughput Screening (HTS) Service Market growing?

Ans: The High Throughput Screening (HTS) Service Market witnessing a CAGR of 10.1% during the forecast period 2026-2032.

What is the High Throughput Screening (HTS) Service Market size in 2032?

Ans: The High Throughput Screening (HTS) Service Market size in 2032 will be US$ 670 million.

Who are the main players in the High Throughput Screening (HTS) Service Market report?

Ans: The main players in the High Throughput Screening (HTS) Service Market are Eurofins Discovery, Charles River Laboratories, Axcelead, NUVISAN, Axxam S.p.A., Evotec, Selvita, Azenta Life Sciences, Bienta (Enamine), Cayman Chemical, Creative Biolabs, Creative Bioarray, BOC Sciences, MEDICILON, Domainex, Creative Diagnostics, Multispan, AntalGenics, Creative Biostructure, BPS Bioscience

What are the Application segmentation covered in the High Throughput Screening (HTS) Service Market report?

Ans: The Applications covered in the High Throughput Screening (HTS) Service Market report are Pharmaceutical Industry, Universities and Scientific Research Institutions

What are the Type segmentation covered in the High Throughput Screening (HTS) Service Market report?

Ans: The Types covered in the High Throughput Screening (HTS) Service Market report are Chemical-based HTS Service, Biological-based HTS Service, Cell-based HTS Service, Genetic-based HTS Service

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global High Throughput Screening (HTS) Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Chemical-based HTS Service
1.2.3 Biological-based HTS Service
1.2.4 Cell-based HTS Service
1.2.5 Genetic-based HTS Service
1.3 Market by Detection Technology Principle
1.3.1 Global High Throughput Screening (HTS) Service Market Size Growth Rate by Detection Technology Principle: 2021 vs 2025 vs 2032
1.3.2 Fluorescence-based HTS
1.3.3 Luminescence-based HTS
1.3.4 Label-free HTS
1.4 Market by Sample Format and Scale
1.4.1 Global High Throughput Screening (HTS) Service Market Size Growth Rate by Sample Format and Scale: 2021 vs 2025 vs 2032
1.4.2 Microwell Plate-based HTS
1.4.3 Droplet-based HTS
1.4.4 Array-based HTS
1.5 Market by Application
1.5.1 Global High Throughput Screening (HTS) Service Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Pharmaceutical Industry
1.5.3 Universities and Scientific Research Institutions
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global High Throughput Screening (HTS) Service Market Perspective (2021–2032)
2.2 Global High Throughput Screening (HTS) Service Growth Trends by Region
2.2.1 Global High Throughput Screening (HTS) Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 High Throughput Screening (HTS) Service Historic Market Size by Region (2021–2026)
2.2.3 High Throughput Screening (HTS) Service Forecasted Market Size by Region (2027–2032)
2.3 High Throughput Screening (HTS) Service Market Dynamics
2.3.1 High Throughput Screening (HTS) Service Industry Trends
2.3.2 High Throughput Screening (HTS) Service Market Drivers
2.3.3 High Throughput Screening (HTS) Service Market Challenges
2.3.4 High Throughput Screening (HTS) Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top High Throughput Screening (HTS) Service Players by Revenue
3.1.1 Global Top High Throughput Screening (HTS) Service Players by Revenue (2021–2026)
3.1.2 Global High Throughput Screening (HTS) Service Revenue Market Share by Players (2021–2026)
3.2 Global Top High Throughput Screening (HTS) Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by High Throughput Screening (HTS) Service Revenue
3.4 Global High Throughput Screening (HTS) Service Market Concentration Ratio
3.4.1 Global High Throughput Screening (HTS) Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by High Throughput Screening (HTS) Service Revenue in 2025
3.5 Global Key Players of High Throughput Screening (HTS) Service Head Offices and Areas Served
3.6 Global Key Players of High Throughput Screening (HTS) Service, Products and Applications
3.7 Global Key Players of High Throughput Screening (HTS) Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 High Throughput Screening (HTS) Service Breakdown Data by Type
4.1 Global High Throughput Screening (HTS) Service Historic Market Size by Type (2021–2026)
4.2 Global High Throughput Screening (HTS) Service Forecasted Market Size by Type (2027–2032)
5 High Throughput Screening (HTS) Service Breakdown Data by Application
5.1 Global High Throughput Screening (HTS) Service Historic Market Size by Application (2021–2026)
5.2 Global High Throughput Screening (HTS) Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America High Throughput Screening (HTS) Service Market Size (2021–2032)
6.2 North America High Throughput Screening (HTS) Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America High Throughput Screening (HTS) Service Market Size by Country (2021–2026)
6.4 North America High Throughput Screening (HTS) Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe High Throughput Screening (HTS) Service Market Size (2021–2032)
7.2 Europe High Throughput Screening (HTS) Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe High Throughput Screening (HTS) Service Market Size by Country (2021–2026)
7.4 Europe High Throughput Screening (HTS) Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific High Throughput Screening (HTS) Service Market Size (2021–2032)
8.2 Asia-Pacific High Throughput Screening (HTS) Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific High Throughput Screening (HTS) Service Market Size by Region (2021–2026)
8.4 Asia-Pacific High Throughput Screening (HTS) Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America High Throughput Screening (HTS) Service Market Size (2021–2032)
9.2 Latin America High Throughput Screening (HTS) Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America High Throughput Screening (HTS) Service Market Size by Country (2021–2026)
9.4 Latin America High Throughput Screening (HTS) Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa High Throughput Screening (HTS) Service Market Size (2021–2032)
10.2 Middle East & Africa High Throughput Screening (HTS) Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa High Throughput Screening (HTS) Service Market Size by Country (2021–2026)
10.4 Middle East & Africa High Throughput Screening (HTS) Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Discovery
11.1.1 Eurofins Discovery Company Details
11.1.2 Eurofins Discovery Business Overview
11.1.3 Eurofins Discovery High Throughput Screening (HTS) Service Introduction
11.1.4 Eurofins Discovery Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.1.5 Eurofins Discovery Recent Development
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Details
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories High Throughput Screening (HTS) Service Introduction
11.2.4 Charles River Laboratories Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.2.5 Charles River Laboratories Recent Development
11.3 Axcelead
11.3.1 Axcelead Company Details
11.3.2 Axcelead Business Overview
11.3.3 Axcelead High Throughput Screening (HTS) Service Introduction
11.3.4 Axcelead Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.3.5 Axcelead Recent Development
11.4 NUVISAN
11.4.1 NUVISAN Company Details
11.4.2 NUVISAN Business Overview
11.4.3 NUVISAN High Throughput Screening (HTS) Service Introduction
11.4.4 NUVISAN Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.4.5 NUVISAN Recent Development
11.5 Axxam S.p.A.
11.5.1 Axxam S.p.A. Company Details
11.5.2 Axxam S.p.A. Business Overview
11.5.3 Axxam S.p.A. High Throughput Screening (HTS) Service Introduction
11.5.4 Axxam S.p.A. Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.5.5 Axxam S.p.A. Recent Development
11.6 Evotec
11.6.1 Evotec Company Details
11.6.2 Evotec Business Overview
11.6.3 Evotec High Throughput Screening (HTS) Service Introduction
11.6.4 Evotec Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.6.5 Evotec Recent Development
11.7 Selvita
11.7.1 Selvita Company Details
11.7.2 Selvita Business Overview
11.7.3 Selvita High Throughput Screening (HTS) Service Introduction
11.7.4 Selvita Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.7.5 Selvita Recent Development
11.8 Azenta Life Sciences
11.8.1 Azenta Life Sciences Company Details
11.8.2 Azenta Life Sciences Business Overview
11.8.3 Azenta Life Sciences High Throughput Screening (HTS) Service Introduction
11.8.4 Azenta Life Sciences Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.8.5 Azenta Life Sciences Recent Development
11.9 Bienta (Enamine)
11.9.1 Bienta (Enamine) Company Details
11.9.2 Bienta (Enamine) Business Overview
11.9.3 Bienta (Enamine) High Throughput Screening (HTS) Service Introduction
11.9.4 Bienta (Enamine) Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.9.5 Bienta (Enamine) Recent Development
11.10 Cayman Chemical
11.10.1 Cayman Chemical Company Details
11.10.2 Cayman Chemical Business Overview
11.10.3 Cayman Chemical High Throughput Screening (HTS) Service Introduction
11.10.4 Cayman Chemical Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.10.5 Cayman Chemical Recent Development
11.11 Creative Biolabs
11.11.1 Creative Biolabs Company Details
11.11.2 Creative Biolabs Business Overview
11.11.3 Creative Biolabs High Throughput Screening (HTS) Service Introduction
11.11.4 Creative Biolabs Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.11.5 Creative Biolabs Recent Development
11.12 Creative Bioarray
11.12.1 Creative Bioarray Company Details
11.12.2 Creative Bioarray Business Overview
11.12.3 Creative Bioarray High Throughput Screening (HTS) Service Introduction
11.12.4 Creative Bioarray Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.12.5 Creative Bioarray Recent Development
11.13 BOC Sciences
11.13.1 BOC Sciences Company Details
11.13.2 BOC Sciences Business Overview
11.13.3 BOC Sciences High Throughput Screening (HTS) Service Introduction
11.13.4 BOC Sciences Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.13.5 BOC Sciences Recent Development
11.14 MEDICILON
11.14.1 MEDICILON Company Details
11.14.2 MEDICILON Business Overview
11.14.3 MEDICILON High Throughput Screening (HTS) Service Introduction
11.14.4 MEDICILON Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.14.5 MEDICILON Recent Development
11.15 Domainex
11.15.1 Domainex Company Details
11.15.2 Domainex Business Overview
11.15.3 Domainex High Throughput Screening (HTS) Service Introduction
11.15.4 Domainex Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.15.5 Domainex Recent Development
11.16 Creative Diagnostics
11.16.1 Creative Diagnostics Company Details
11.16.2 Creative Diagnostics Business Overview
11.16.3 Creative Diagnostics High Throughput Screening (HTS) Service Introduction
11.16.4 Creative Diagnostics Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.16.5 Creative Diagnostics Recent Development
11.17 Multispan
11.17.1 Multispan Company Details
11.17.2 Multispan Business Overview
11.17.3 Multispan High Throughput Screening (HTS) Service Introduction
11.17.4 Multispan Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.17.5 Multispan Recent Development
11.18 AntalGenics
11.18.1 AntalGenics Company Details
11.18.2 AntalGenics Business Overview
11.18.3 AntalGenics High Throughput Screening (HTS) Service Introduction
11.18.4 AntalGenics Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.18.5 AntalGenics Recent Development
11.19 Creative Biostructure
11.19.1 Creative Biostructure Company Details
11.19.2 Creative Biostructure Business Overview
11.19.3 Creative Biostructure High Throughput Screening (HTS) Service Introduction
11.19.4 Creative Biostructure Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.19.5 Creative Biostructure Recent Development
11.20 BPS Bioscience
11.20.1 BPS Bioscience Company Details
11.20.2 BPS Bioscience Business Overview
11.20.3 BPS Bioscience High Throughput Screening (HTS) Service Introduction
11.20.4 BPS Bioscience Revenue in High Throughput Screening (HTS) Service Business (2021–2026)
11.20.5 BPS Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global High Throughput Screening (HTS) Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Chemical-based HTS Service
 Table 3. Key Players of Biological-based HTS Service
 Table 4. Key Players of Cell-based HTS Service
 Table 5. Key Players of Genetic-based HTS Service
 Table 6. Global High Throughput Screening (HTS) Service Market Size Growth Rate by Detection Technology Principle (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Key Players of Fluorescence-based HTS
 Table 8. Key Players of Luminescence-based HTS
 Table 9. Key Players of Label-free HTS
 Table 10. Global High Throughput Screening (HTS) Service Market Size Growth Rate by Sample Format and Scale (US$ Million): 2021 vs 2025 vs 2032
 Table 11. Key Players of Microwell Plate-based HTS
 Table 12. Key Players of Droplet-based HTS
 Table 13. Key Players of Array-based HTS
 Table 14. Global High Throughput Screening (HTS) Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 15. Global High Throughput Screening (HTS) Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 16. Global High Throughput Screening (HTS) Service Market Size by Region (US$ Million), 2021–2026
 Table 17. Global High Throughput Screening (HTS) Service Market Share by Region (2021–2026)
 Table 18. Global High Throughput Screening (HTS) Service Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 19. Global High Throughput Screening (HTS) Service Market Share by Region (2027–2032)
 Table 20. High Throughput Screening (HTS) Service Market Trends
 Table 21. High Throughput Screening (HTS) Service Market Drivers
 Table 22. High Throughput Screening (HTS) Service Market Challenges
 Table 23. High Throughput Screening (HTS) Service Market Restraints
 Table 24. Global High Throughput Screening (HTS) Service Revenue by Players (US$ Million), 2021–2026
 Table 25. Global High Throughput Screening (HTS) Service Market Share by Players (2021–2026)
 Table 26. Global Top High Throughput Screening (HTS) Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on High Throughput Screening (HTS) Service Revenue, 2025
 Table 27. Ranking of Global Top High Throughput Screening (HTS) Service Companies by Revenue (US$ Million) in 2025
 Table 28. Global 5 Largest Players Market Share by High Throughput Screening (HTS) Service Revenue (CR5 and HHI), 2021–2026
 Table 29. Global Key Players of High Throughput Screening (HTS) Service, Headquarters and Area Served
 Table 30. Global Key Players of High Throughput Screening (HTS) Service, Products and Applications
 Table 31. Global Key Players of High Throughput Screening (HTS) Service, Date of General Availability (GA)
 Table 32. Mergers and Acquisitions, Expansion Plans
 Table 33. Global High Throughput Screening (HTS) Service Market Size by Type (US$ Million), 2021–2026
 Table 34. Global High Throughput Screening (HTS) Service Revenue Market Share by Type (2021–2026)
 Table 35. Global High Throughput Screening (HTS) Service Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 36. Global High Throughput Screening (HTS) Service Revenue Market Share by Type (2027–2032)
 Table 37. Global High Throughput Screening (HTS) Service Market Size by Application (US$ Million), 2021–2026
 Table 38. Global High Throughput Screening (HTS) Service Revenue Market Share by Application (2021–2026)
 Table 39. Global High Throughput Screening (HTS) Service Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 40. Global High Throughput Screening (HTS) Service Revenue Market Share by Application (2027–2032)
 Table 41. North America High Throughput Screening (HTS) Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. North America High Throughput Screening (HTS) Service Market Size by Country (US$ Million), 2021–2026
 Table 43. North America High Throughput Screening (HTS) Service Market Size by Country (US$ Million), 2027–2032
 Table 44. Europe High Throughput Screening (HTS) Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Europe High Throughput Screening (HTS) Service Market Size by Country (US$ Million), 2021–2026
 Table 46. Europe High Throughput Screening (HTS) Service Market Size by Country (US$ Million), 2027–2032
 Table 47. Asia-Pacific High Throughput Screening (HTS) Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 48. Asia-Pacific High Throughput Screening (HTS) Service Market Size by Region (US$ Million), 2021–2026
 Table 49. Asia-Pacific High Throughput Screening (HTS) Service Market Size by Region (US$ Million), 2027–2032
 Table 50. Latin America High Throughput Screening (HTS) Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 51. Latin America High Throughput Screening (HTS) Service Market Size by Country (US$ Million), 2021–2026
 Table 52. Latin America High Throughput Screening (HTS) Service Market Size by Country (US$ Million), 2027–2032
 Table 53. Middle East & Africa High Throughput Screening (HTS) Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 54. Middle East & Africa High Throughput Screening (HTS) Service Market Size by Country (US$ Million), 2021–2026
 Table 55. Middle East & Africa High Throughput Screening (HTS) Service Market Size by Country (US$ Million), 2027–2032
 Table 56. Eurofins Discovery Company Details
 Table 57. Eurofins Discovery Business Overview
 Table 58. Eurofins Discovery High Throughput Screening (HTS) Service Product
 Table 59. Eurofins Discovery Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 60. Eurofins Discovery Recent Development
 Table 61. Charles River Laboratories Company Details
 Table 62. Charles River Laboratories Business Overview
 Table 63. Charles River Laboratories High Throughput Screening (HTS) Service Product
 Table 64. Charles River Laboratories Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 65. Charles River Laboratories Recent Development
 Table 66. Axcelead Company Details
 Table 67. Axcelead Business Overview
 Table 68. Axcelead High Throughput Screening (HTS) Service Product
 Table 69. Axcelead Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 70. Axcelead Recent Development
 Table 71. NUVISAN Company Details
 Table 72. NUVISAN Business Overview
 Table 73. NUVISAN High Throughput Screening (HTS) Service Product
 Table 74. NUVISAN Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 75. NUVISAN Recent Development
 Table 76. Axxam S.p.A. Company Details
 Table 77. Axxam S.p.A. Business Overview
 Table 78. Axxam S.p.A. High Throughput Screening (HTS) Service Product
 Table 79. Axxam S.p.A. Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 80. Axxam S.p.A. Recent Development
 Table 81. Evotec Company Details
 Table 82. Evotec Business Overview
 Table 83. Evotec High Throughput Screening (HTS) Service Product
 Table 84. Evotec Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 85. Evotec Recent Development
 Table 86. Selvita Company Details
 Table 87. Selvita Business Overview
 Table 88. Selvita High Throughput Screening (HTS) Service Product
 Table 89. Selvita Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 90. Selvita Recent Development
 Table 91. Azenta Life Sciences Company Details
 Table 92. Azenta Life Sciences Business Overview
 Table 93. Azenta Life Sciences High Throughput Screening (HTS) Service Product
 Table 94. Azenta Life Sciences Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 95. Azenta Life Sciences Recent Development
 Table 96. Bienta (Enamine) Company Details
 Table 97. Bienta (Enamine) Business Overview
 Table 98. Bienta (Enamine) High Throughput Screening (HTS) Service Product
 Table 99. Bienta (Enamine) Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 100. Bienta (Enamine) Recent Development
 Table 101. Cayman Chemical Company Details
 Table 102. Cayman Chemical Business Overview
 Table 103. Cayman Chemical High Throughput Screening (HTS) Service Product
 Table 104. Cayman Chemical Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 105. Cayman Chemical Recent Development
 Table 106. Creative Biolabs Company Details
 Table 107. Creative Biolabs Business Overview
 Table 108. Creative Biolabs High Throughput Screening (HTS) Service Product
 Table 109. Creative Biolabs Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 110. Creative Biolabs Recent Development
 Table 111. Creative Bioarray Company Details
 Table 112. Creative Bioarray Business Overview
 Table 113. Creative Bioarray High Throughput Screening (HTS) Service Product
 Table 114. Creative Bioarray Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 115. Creative Bioarray Recent Development
 Table 116. BOC Sciences Company Details
 Table 117. BOC Sciences Business Overview
 Table 118. BOC Sciences High Throughput Screening (HTS) Service Product
 Table 119. BOC Sciences Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 120. BOC Sciences Recent Development
 Table 121. MEDICILON Company Details
 Table 122. MEDICILON Business Overview
 Table 123. MEDICILON High Throughput Screening (HTS) Service Product
 Table 124. MEDICILON Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 125. MEDICILON Recent Development
 Table 126. Domainex Company Details
 Table 127. Domainex Business Overview
 Table 128. Domainex High Throughput Screening (HTS) Service Product
 Table 129. Domainex Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 130. Domainex Recent Development
 Table 131. Creative Diagnostics Company Details
 Table 132. Creative Diagnostics Business Overview
 Table 133. Creative Diagnostics High Throughput Screening (HTS) Service Product
 Table 134. Creative Diagnostics Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 135. Creative Diagnostics Recent Development
 Table 136. Multispan Company Details
 Table 137. Multispan Business Overview
 Table 138. Multispan High Throughput Screening (HTS) Service Product
 Table 139. Multispan Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 140. Multispan Recent Development
 Table 141. AntalGenics Company Details
 Table 142. AntalGenics Business Overview
 Table 143. AntalGenics High Throughput Screening (HTS) Service Product
 Table 144. AntalGenics Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 145. AntalGenics Recent Development
 Table 146. Creative Biostructure Company Details
 Table 147. Creative Biostructure Business Overview
 Table 148. Creative Biostructure High Throughput Screening (HTS) Service Product
 Table 149. Creative Biostructure Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 150. Creative Biostructure Recent Development
 Table 151. BPS Bioscience Company Details
 Table 152. BPS Bioscience Business Overview
 Table 153. BPS Bioscience High Throughput Screening (HTS) Service Product
 Table 154. BPS Bioscience Revenue in High Throughput Screening (HTS) Service Business (US$ Million), 2021–2026
 Table 155. BPS Bioscience Recent Development
 Table 156. Research Programs/Design for This Report
 Table 157. Key Data Information from Secondary Sources
 Table 158. Key Data Information from Primary Sources
 Table 159. Authors List of This Report


List of Figures
 Figure 1. High Throughput Screening (HTS) Service Picture
 Figure 2. Global High Throughput Screening (HTS) Service Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global High Throughput Screening (HTS) Service Market Share by Type: 2025 vs 2032
 Figure 4. Chemical-based HTS Service Features
 Figure 5. Biological-based HTS Service Features
 Figure 6. Cell-based HTS Service Features
 Figure 7. Genetic-based HTS Service Features
 Figure 8. Global High Throughput Screening (HTS) Service Market Size Comparison by Detection Technology Principle (US$ Million), 2021–2032
 Figure 9. Fluorescence-based HTS Features
 Figure 10. Luminescence-based HTS Features
 Figure 11. Label-free HTS Features
 Figure 12. Global High Throughput Screening (HTS) Service Market Size Comparison by Sample Format and Scale (US$ Million), 2021–2032
 Figure 13. Microwell Plate-based HTS Features
 Figure 14. Droplet-based HTS Features
 Figure 15. Array-based HTS Features
 Figure 16. Global High Throughput Screening (HTS) Service Market Size by Application (US$ Million), 2021–2032
 Figure 17. Global High Throughput Screening (HTS) Service Market Share by Application: 2025 vs 2032
 Figure 18. Pharmaceutical Industry Case Studies
 Figure 19. Universities and Scientific Research Institutions Case Studies
 Figure 20. High Throughput Screening (HTS) Service Report Years Considered
 Figure 21. Global High Throughput Screening (HTS) Service Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 22. Global High Throughput Screening (HTS) Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 23. Global High Throughput Screening (HTS) Service Market Share by Region: 2025 vs 2032
 Figure 24. Global High Throughput Screening (HTS) Service Market Share by Players in 2025
 Figure 25. Global High Throughput Screening (HTS) Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 26. The Top 10 and 5 Players Market Share by High Throughput Screening (HTS) Service Revenue in 2025
 Figure 27. North America High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. North America High Throughput Screening (HTS) Service Market Share by Country (2021–2032)
 Figure 29. United States High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Canada High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Europe High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Europe High Throughput Screening (HTS) Service Market Share by Country (2021–2032)
 Figure 33. Germany High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. France High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. U.K. High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Italy High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Russia High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Ireland High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Asia-Pacific High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Asia-Pacific High Throughput Screening (HTS) Service Market Share by Region (2021–2032)
 Figure 41. China High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Japan High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. South Korea High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Southeast Asia High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. India High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Australia & New Zealand High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Latin America High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Latin America High Throughput Screening (HTS) Service Market Share by Country (2021–2032)
 Figure 49. Mexico High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. Brazil High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. Middle East & Africa High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 52. Middle East & Africa High Throughput Screening (HTS) Service Market Share by Country (2021–2032)
 Figure 53. Israel High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 54. Saudi Arabia High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 55. UAE High Throughput Screening (HTS) Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 56. Eurofins Discovery Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 57. Charles River Laboratories Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 58. Axcelead Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 59. NUVISAN Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 60. Axxam S.p.A. Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 61. Evotec Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 62. Selvita Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 63. Azenta Life Sciences Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 64. Bienta (Enamine) Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 65. Cayman Chemical Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 66. Creative Biolabs Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 67. Creative Bioarray Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 68. BOC Sciences Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 69. MEDICILON Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 70. Domainex Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 71. Creative Diagnostics Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 72. Multispan Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 73. AntalGenics Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 74. Creative Biostructure Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 75. BPS Bioscience Revenue Growth Rate in High Throughput Screening (HTS) Service Business (2021–2026)
 Figure 76. Bottom-up and Top-down Approaches for This Report
 Figure 77. Data Triangulation
 Figure 78. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture